Lupus Trial, Recruiting NCT06778343 Sponsor: Universidade Nova de Lisboa Condition: Lupus
Back to Lupus

Lupus Trial, Recruiting

NCT06778343
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with ankylosing spondylitis (AS), rheumatoid arthritis (RA), or lupus (SLE)
  • You are able to understand and sign a consent form agreeing to take part
  • If you are currently taking certain pain medications (such as anti-inflammatory drugs, tramadol, or paracetamol with codeine), you have been on the same dose for at least 14 days before your first study visit
  • If you are taking steroid tablets (such as prednisone), you have been on a low, stable dose for at least 14 days before your first study visit
  • If you are taking certain disease-modifying medications (such as methotrexate, leflunomide, sulfasalazine, or hydroxychloroquine), you have been on a stable dose for at least 28 days before your first study visit
  • The study doctor considers you to be in generally good health based on your medical history, blood tests, physical exam, and X-ray

Who may not be able to join:

  • You are currently pregnant or breastfeeding
  • You have previously been treated with any biological therapy (a type of advanced medication used for immune conditions)
  • You have had a steroid injection into a joint, tendon, or spine within the past 28 days (inhaled or skin-applied steroids are allowed)
  • You have received a live vaccine within the past 4 weeks
  • You have had a significant problem with drug or alcohol use in the last 6 months
  • You have a type of inflammatory joint condition other than AS, RA, or SLE, or you developed any form of arthritis before the age of 17
  • You have any medical condition that is not well controlled, such as uncontrolled diabetes or unstable heart disease
  • You have a history of any type of cancer
  • You have tested positive for hepatitis B, hepatitis C, or HIV
  • You have had an infection requiring hospital treatment or IV antibiotics in the last 30 days, or oral antibiotics in the last 14 days
  • For healthy volunteers specifically: you have had a recent acute illness or injury in the last 6 months, a poorly controlled chronic condition, or a family history of autoimmune diseases diagnosed by a rheumatologist (confirm with trial site)

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 00351917305093

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Universidade Nova de Lisboa
Registry
ClinicalTrials.gov
Start date
31 January 2023
Est. completion
31 March 2025

Where this trial is recruiting

🇵🇹 Portugal

Primary endpoints

Identify a transcriptomic signature to optimize patient stratification (between AS, RA and SLE)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov